Market cap
₹16 Cr
Revenue (TTM)
₹339 Cr
P/E Ratio
7.8
P/B Ratio
2.4
Div. Yield
0 %
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
16 | 16,921 | 17,015 | 7,702 | 5,892 |
Revenue (₹ Cr) |
339 | 3,915 | 4,537 | 2,966 | 1,240 |
Net Profit (₹ Cr) |
2.03 | 753.50 | 188.20 | 284.04 | 223.00 |
Net Margin (%) |
0.60 | 18.85 | 4.14 | 9.37 | 17.60 |
RoE (%) |
3.93 | 25.89 | 3.99 | 18.77 | 31.86 |
Price to Earnings |
7.79 | 22.61 | 90.41 | 27.12 | 26.42 |
Price-To-Book |
2.37 | 5.52 | 2.86 | 4.71 | 7.15 |
Income Statement (₹ Cr)
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Operating Revenue
|
339.18 | 3,914.63 | 4,537.10 | 2,846.98 | 1,239.59 |
|
Total Income
|
340.02 | 3,996.65 | 4,545.90 | 2,902.56 | 1,266.93 |
|
Total Expenditure
|
331.99 | 2,939.02 | 3,942.90 | 2,347.39 | 975.78 |
|
EBITDA
|
7.18 | 975.61 | 594.20 | 499.59 | 263.81 |
|
Depreciation
|
1.03 | 175.60 | 193.00 | 56.13 | 16.73 |
|
EBIT
|
6.16 | 800.01 | 401.20 | 443.46 | 247.08 |
|
Interest
|
4.17 | 14.31 | 121.90 | 5.93 | 1.57 |
|
Other Income
|
0.84 | 82.02 | 8.80 | 55.58 | 27.35 |
|
Exceptional Items
|
-0.17 | -10.15 | -40.80 | -4.30 | 0.00 |
|
Profit before Tax
|
2.66 | 857.57 | 247.30 | 488.81 | 272.85 |
|
Provision for Tax
|
0.64 | 104.07 | 59.10 | 118.43 | 49.85 |
|
Profit after Tax
|
2.03 | 753.50 | 188.20 | 370.38 | 223.00 |
Liabilities (₹ Cr)
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
55.02 | 2,923.98 | 5,826.00 | 2,049.51 | 754.98 |
|
Minority Interest
|
0.00 | -1.58 | 0.00 | 1.90 | 0.00 |
|
Non-Current Liabilities
|
1.76 | 75.76 | 3,753.30 | 604.31 | 16.17 |
|
Current Liabilities
|
91.10 | 838.24 | 728.50 | 592.76 | 173.98 |
|
Total Liabilities
|
143.44 | 3,525.22 | 6,441.90 | 3,273.92 | 901.07 |
Assets (₹ Cr)
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
13.62 | 1,839.04 | 8,738.00 | 1,753.16 | 310.99 |
|
Current Assets
|
133.50 | 1,934.86 | 1,366.70 | 1,493.42 | 607.49 |
|
Total Assets
|
143.44 | 3,525.22 | 6,441.90 | 3,273.92 | 901.07 |
|
Total Debt*
|
56.67 | 62.08 | 185.00 | 0.00 | 0.00 |
|
Net Current Assets
|
42.40 | 1,096.62 | 638.20 | 900.66 | 433.52 |
|
Contingent Liabilities
|
0.17 | 13.24 | 351.30 | 9.61 | 9.32 |
Cashflow (₹ Cr)
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-0.67 | 895.86 | 380.00 | 311.41 | 65.10 |
|
Cash Flow from Investing Activities
|
-0.41 | -340.14 | -223.60 | -161.10 | 155.33 |
|
Cash from Financing Activities
|
1.05 | -499.61 | -186.30 | -157.47 | -211.59 |
|
Net Cash Inflow / Outflow
|
-0.03 | 56.11 | -29.90 | -7.16 | 8.84 |
Ratios
Profitability Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
ROCE (%)
|
7.43 | 34.28 | 6.43 | 25.65 | 19.42 |
|
ROE (%)
|
3.93 | 25.89 | 3.99 | 19.21 | 31.86 |
|
ROA (%)
|
1.39 | 20.45 | 2.25 | 12.17 | 24.16 |
|
EBIT Margin (%)
|
1.81 | 20.44 | 8.84 | 19.50 | 19.93 |
|
Net Margin (%)
|
0.60 | 18.85 | 4.14 | 12.76 | 17.60 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 11.96 | 0.00 |
Growth Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
20.24 | 2.82 | 66.27 | 3.27 | 24.92 |
|
EBIT Growth (%)
|
-4.63 | -5.27 | 15.99 | 4.06 | 103.25 |
|
Net Profit Growth (%)
|
44.51 | -9.02 | -42.46 | 0.29 | 76.99 |
|
EPS Growth (%)
|
52.91 | -7.37 | -85.70 | 0.27 | 83.44 |
|
Book Value Growth (%)
|
4.07 | 10.14 | 5.86 | 13.33 | -9.96 |
Valuation Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Price / Earnings
|
7.36 | 22.33 | 73.90 | 32.58 | 26.66 |
|
Price / Book Value
|
2.37 | 5.52 | 2.86 | 5.89 | 7.15 |
|
Dividend Yield (%)
|
0.00 | 2.58 | 0.22 | 1.07 | 0.00 |
|
EV/EBITDA
|
10.08 | 16.57 | 33.80 | 21.48 | 20.80 |
|
Market Cap (₹ Cr)
|
-- | 25,301.77 | 10,631.08 | 12,068.06 | 2,155.13 |
Solvency Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.01 | 0.00 | 0.52 | 0.00 | 0.00 |
|
Short term debt to equity ratio
|
1.03 | 0.02 | 0.03 | -- | -- |
|
Current Ratio
|
1.47 | 2.31 | 1.88 | 2.52 | 3.49 |
|
Quick Ratio
|
0.47 | 1.83 | 0.83 | 1.97 | 3.11 |
|
Interest Coverage
|
1.64 | 60.93 | 3.03 | 83.43 | 174.68 |
Operating Efficiency Ratios
| Olympia | Emami | Zydus Wellness | Jyothy Labs | Bajaj Consumer | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
12.27 | 8.77 | 8.46 | 9.64 | 6.10 |
|
Asset Turnover
|
2.33 | 1.06 | 0.54 | 1.17 | 1.34 |
|
Receivable days
|
40.10 | 45.30 | 40.43 | 24.35 | 21.91 |
|
Inventory Days
|
114.66 | 30.26 | 61.24 | 31.30 | 20.99 |
|
Payable days
|
45.85 | 136.04 | 113.05 | 72.82 | 37.24 |
|
Cash Conversion Cycle
|
108.92 | -60.48 | -11.38 | -17.16 | 5.66 |